ANGELA HARRIS-BONNER: Open Payments
NPI 1134566334 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,038 in 115 payments from 8 companies in 2025. Trend: 2023 $1,578 · 2024 $2,622 · 2025 $7,038
Consulting: $3,000Food & beverage: $2,861Travel & lodging: $1,176
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $4,725 |
| ABBVIE INC. | 53 | $1,201 |
| Teva Pharmaceuticals USA, Inc. | 23 | $332 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $312 |
| Axsome Therapeutics, Inc. | 3 | $177 |
| Alkermes, Inc. | 2 | $144 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: RINVOQ, VRAYLAR, CAPLYTA, SKYRIZI, UZEDY, COBENFY, Auvelity, ARISTADA.
Industry payments across VA — which companies pay providers there.
